EUVIMEDDescoperă EUVIMED
Randomisierte kontrollierte StudieOpen access · CC BY-NC-ND 4.0

Intraoperative indocyanine green fluorescence angiography in colorectal surgery to prevent anastomotic leakage: A single‐blind phase III multicentre randomized controlled trial ( FLUOCOL ‐01/ FRENCH 21/ GRECCAR 19 intergroup trial)

Jean-Baptiste Pretalli iD, Dewi Vernerey iD, Philippe Evrard, Astrid Pozet iD, Anne-Laure Clairet iD, Stéphane Benoist iD, Mehdi Karoui iD, Eddy Cotte iD, Bruno Heyd iD, Zaher Lakkis iD, FLUOCOL Study Group

Colorectal Disease · 2025-05 · 27 (5)

DOI: 10.1111/codi.70119 ↗

At a glance

Randomisierte kontrollierte Studie in Colorectal Disease, published online on 2025-05-25. Written by Jean-Baptiste Pretalli and 10 co-authors. Institution: Department of Digestive Surgical Oncology-Liver Transplantation Unit, University Hospital of Besançon, Besançon, France. Major MEDLINE topics: Anastomotic Leak, Colorectal Neoplasms, Fluorescein Angiography, Indocyanine Green. Cited 7 times so far (Crossref); 36 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Programme Hospitalier de Recherche Clinique-Cancer, French Ministry of Health.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Aim

Anastomotic leak (AL) is a major problem in colorectal surgery, and its prevention is crucial for patient safety. The scientific literature shows that optimal anastomotic perfusion is essential for anastomotic healing. However, in cases of left colon or rectal cancer requiring high vessel ligation for oncological reasons, anastomotic blood supply relies mainly on the pericolic arterial arcades. Consequently, assessing anastomotic perfusion using intraoperative fluorescence angiography with indocyanine green might be relevant to reduce the risk of AL. Although evidence of its positive impact on the risk of AL is growing in the literature, most studies are descriptive prospective cohorts or retrospective comparative series with controversial findings. Furthermore, no other studies specifically address left‐sided colon or high rectal tumours. FLUOCOL‐1 is a large multicentre randomized controlled trial (RCT) that aims to demonstrate that assessing anastomotic perfusion using intraoperative fluorescence angiography with indocyanine green will reduce ALs in left‐sided or high anterior resections with intraperitoneal anastomosis Method FLUOCOL‐1 is a French multicentre, single‐blind, randomized, two‐arm, phase III superiority clinical trial. Patients will be randomized in a 1:1 ratio to either the intervention group (FLUO+) or the control group (FLUO−). A total of 1010 patients will be randomized. The primary endpoint is the occurrence of an AL within 90 days postsurgery. AL is defined as any anastomotic dehiscence with leakage into the pelvic cavity diagnosed by imaging or surgical exploration, or any isolated pelvic organ‐space infection with no evidence of fistula, as defined by the International Study Group of Rectal Cancer.

Discussion

Prevention of AL is one of the most important questions to be addressed in colorectal surgery. The FLUOCOL‐1 multicentre RCT described herein aims to demonstrate that assessment of anastomotic perfusion using intraoperative fluorescence angiography with indocyanine green will reduce ALs in certain resections with intraperitoneal anastomosis.

Subjects

MeSH terms (MEDLINE)

Anastomotic LeakColorectal NeoplasmsFluorescein AngiographyIndocyanine GreenIntraoperative CareFemaleHumansMaleAnastomosis, SurgicalClinical Trials, Phase III as TopicColonColorectal SurgeryColoring AgentsFranceMulticenter Studies as TopicRandomized Controlled Trials as TopicSingle-Blind Method

Author keywords

anastomotic leakagecolic surgerycolorectal surgerycomplicationfluorescence angiographyindocyanine greenprevention

Substances

Coloring AgentsIndocyanine Green

Authors and institutions

  • Department of Digestive Surgical Oncology-Liver Transplantation Unit, University Hospital of Besançon, Besançon, France.
  • INSERM CIC 1431, Centre d'Investigation Clinique, University Hospital of Besançon, Besançon, France.
  • Methodology and Quality of Life Unit in Oncology, University of Besançon, Besançon, France.
  • INSERM, Etablissement Français du Sang Bourgogne Franche-Comté, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, Besançon, France.
  • Délégation à la Recherche Clinique et à l'Innovation, University Hospital of Besançon, Besançon, France.
  • Department of Pharmacy, University Hospital of Besançon, Besançon, France.

ORCID profiles: Jean-Baptiste Pretalli, Dewi Vernerey, Astrid Pozet, Anne-Laure Clairet, Stéphane Benoist, Mehdi Karoui, Eddy Cotte, Bruno Heyd, Zaher Lakkis

Funding

  • Programme Hospitalier de Recherche Clinique-Cancer
  • French Ministry of Health

Cite

APA

Pretalli, J. B., Vernerey, D., Evrard, P., Pozet, A., Clairet, A. L., Benoist, S., Karoui, M., Cotte, E., Heyd, B., Lakkis, Z., & FLUOCOL Study Group (2025). Intraoperative indocyanine green fluorescence angiography in colorectal surgery to prevent anastomotic leakage: A single‐blind phase III multicentre randomized controlled trial ( FLUOCOL ‐01/ FRENCH 21/ GRECCAR 19 intergroup trial). Colorectal Disease, 27(5). https://doi.org/10.1111/codi.70119

Vancouver

Pretalli JB, Vernerey D, Evrard P, Pozet A, Clairet AL, Benoist S, et al. Intraoperative indocyanine green fluorescence angiography in colorectal surgery to prevent anastomotic leakage: A single‐blind phase III multicentre randomized controlled trial ( FLUOCOL ‐01/ FRENCH 21/ GRECCAR 19 intergroup trial). Colorectal Disease. 2025;27(5). doi:10.1111/codi.70119

BibTeX
@article{Pretalli2025,
  author = {Pretalli, Jean-Baptiste and Vernerey, Dewi and Evrard, Philippe and Pozet, Astrid and Clairet, Anne-Laure and Benoist, Stéphane and Karoui, Mehdi and Cotte, Eddy and Heyd, Bruno and Lakkis, Zaher and FLUOCOL Study Group, FLUOCOL Study Group},
  title = {Intraoperative indocyanine green fluorescence angiography in colorectal surgery to prevent anastomotic leakage: A single‐blind phase III multicentre randomized controlled trial ( FLUOCOL ‐01/ FRENCH 21/ GRECCAR 19 intergroup trial)},
  journal = {Colorectal Disease},
  year = {2025},
  volume = {27},
  number = {5},
  doi = {10.1111/codi.70119}
}
Start for free →